Merck & Co., Inc. (NYSE:MRK) Ebola Vaccine Attains FDA And EMA Milestone

Merck & Co., Inc. (NYSE:MRK) has just announced that its Ebola vaccine candidate, VSV-ZEBOV has been granted FDA’s BreakthroughTherapy … Full Article http://j.gs/5sTq

Click here to read full article